Newrotex selected for MedTech Innovator 2023 Cohort – the world’s largest MedTech Accelerator

Location:

Newrotex are delighted to announce that we have been selected to join the prestigious MedTech Innovator programme. 61 companies were selected from over 1,150 applicants worldwide and the team will kick off in San Francisco next week. CEO Alex Woods “We’re incredibly proud to have been selected for the MedTech Innovator Accelerator programme including the American Society of Plastic Surgeons (ASPS) cohort. It recognises how our regenerative silk technology can help to address the large unmet need for patients to have a robust and effective treatment for nerve injuries”.

Read previous Read next

Other News

Newrotex Receives Rapid Regulatory Approval in Panama for First-in-Human Trial of SilkAxons™ Nerve Regeneration Technology

Breakthrough spider silk nerve guide set to transform peripheral nerve repair; clinical trial to launch at The Panama Clinic with bioaccess® as CRO partner Newrotex Limited has received regulatory app

Newrotex Founders Dr Alex Woods and Professor Fritz Vollrath were interviewed by Sean Hargrave for Oxford University Innovation in a great piece “Spiders, Surgery and Sustainable Silk” released today.

The article describes some of the incredible uses of silk and the work we’re doing to bring a new standard of treatment for patient’s who have suffered catastrophic nerve injuries. Check out the artic